ALK-Abello A/S (AKBLF)
37.92
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
ALK-Abello Shareholders Equity (Quarterly) : 1.062B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.062B |
| March 31, 2026 | 1.013B |
| December 31, 2025 | 1.013B |
| September 30, 2025 | 971.70M |
| June 30, 2025 | 919.95M |
| March 31, 2025 | 821.81M |
| December 31, 2024 | 746.08M |
| September 30, 2024 | 761.43M |
| June 30, 2024 | 706.94M |
| March 31, 2024 | 679.07M |
| December 31, 2023 | 658.98M |
| September 30, 2023 | 616.34M |
| June 30, 2023 | 613.05M |
| March 31, 2023 | 600.59M |
| December 31, 2022 | 572.34M |
| September 30, 2022 | 520.16M |
| June 30, 2022 | 532.24M |
| March 31, 2022 | 546.87M |
| December 31, 2021 | 532.09M |
| September 30, 2021 | 516.51M |
| June 30, 2021 | 518.14M |
| March 31, 2021 | 525.13M |
| December 31, 2020 | 518.29M |
| September 30, 2020 | 504.59M |
| June 30, 2020 | 488.70M |
| Date | Value |
|---|---|
| March 31, 2020 | 482.15M |
| December 31, 2019 | 477.09M |
| September 30, 2019 | 463.89M |
| June 30, 2019 | 481.69M |
| March 31, 2019 | 489.12M |
| December 31, 2018 | 486.98M |
| September 30, 2018 | 512.28M |
| June 30, 2018 | 518.06M |
| March 31, 2018 | 542.33M |
| December 31, 2017 | 530.61M |
| September 30, 2017 | 437.82M |
| June 30, 2017 | 427.53M |
| March 31, 2017 | 406.03M |
| December 31, 2016 | 407.83M |
| September 30, 2016 | 428.32M |
| June 30, 2016 | 424.38M |
| March 31, 2016 | 422.46M |
| December 31, 2015 | 392.59M |
| September 30, 2015 | 380.95M |
| June 30, 2015 | 371.16M |
| March 31, 2015 | 352.21M |
| December 31, 2014 | 382.53M |
| September 30, 2014 | 397.95M |
| June 30, 2014 | 422.02M |
| March 31, 2014 | 423.30M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Novo Nordisk A/S | 33.84B |
| H. Lundbeck A/S | 4.109B |
| AstraZeneca PLC | 47.33B |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.487B |
| Total Liabilities (Quarterly) | 425.67M |
| Debt to Equity Ratio | 0.0608 |
| Current Ratio | 3.457 |
| Net Debt Paydown Yield | 0.11% |